SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced ...
Austin, Texas, July 1st, 2026, FinanceWireAdvances in digital health, cloud computing and data analytics are making it ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...
HeartBeam BEAT recently secured FDA 510(k) clearance for its first-of-its-kind, cable-free synthesized 12-lead ECG technology, marking a major inflection point in the company’s mission to modernize ...
The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors should trust the model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results